Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.
A growth factor protein produced by rare immune cells in the intestine can protect against the effects of inflammatory bowel disease, according to a new discovery from Weill Cornell Medicine researchers.
Treatment with the amino acid arginine enhanced the effectiveness of radiation therapy in cancer patients with brain metastases in a clinical trial from investigators at Weill Cornell Medicine and Angel H. Roffo Cancer Institute.
Working with the Armenian delegation at COP26, Allison Chatrchyan aims to shape U.N. agriculture policy to reduce greenhouse gas emissions and increase carbon sequestration.
The Eclectic Convergence conference included talks from six entrepreneurs, business executives and venture capitalists, as well as a pitch competition.
A team of graduate students in food science, mechanical engineering and biological engineering is among the winners of Phase 1 of the NASA Deep Space Food Challenge.
As many as one in four children in Flint, Michigan – far above the national average – may have experienced elevated blood lead levels after the city’s 2014 water crisis, finds new research by Jerel Ezell, assistant professor in the Africana Studies and Research Center.
Three distinguished Weill Cornell Medicine physician-scientists, Dr. Joseph J. Fins, Dr. Rainu Kaushal and Dr. Shahin Rafii, have been elected to the Association of American Physicians.
Cornell researchers’ concept for a mobile phone-based system to detect infectious diseases and nutritional deficiencies in saliva was awarded a $100,000 NIH Technology Accelerator Challenge prize.
